- Home
- TRIP vs BCRX Comparison
TRIP vs BCRX Comparison
Compare TRIP & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRIP | BCRX |
|---|---|---|
| Founded | 2000 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2011 | 1994 |
Fundamental Metrics
Financial Performance| Metric | TRIP | BCRX |
|---|---|---|
| Price | $15.24 | $7.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $16.25 | ★ $19.00 |
| AVG Volume (30 Days) | 2.5M | ★ 4.1M |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 124.53 | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $1,891,000,000.00 | $599,816,000.00 |
| Revenue This Year | $5.18 | $40.20 |
| Revenue Next Year | $5.08 | $7.71 |
| P/E Ratio | $26.15 | ★ N/A |
| Revenue Growth | 4.25 | ★ 45.38 |
| 52 Week Low | $10.43 | $6.00 |
| 52 Week High | $20.16 | $11.31 |
Technical Indicators
Market Signals| Indicator | TRIP | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 59.28 |
| Support Level | $14.56 | $7.11 |
| Resistance Level | $15.40 | $8.17 |
| Average True Range (ATR) | 0.62 | 0.30 |
| MACD | 0.11 | 0.09 |
| Stochastic Oscillator | 91.59 | 60.41 |
Price Performance
Historical ComparisonAbout TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of sales in 2024, and TheFork, its dining brand, represented 10% of revenue (about 8% of sales were intersegment, which are eliminated from consolidated revenue).
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.